Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Investigate common budgeting blockers that prevent savings and identify actionable changes. This intro guides you toward steady, growing savings.
27,247 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Gold is climbing as central banks snapping gold drives a new bid, with ETF buyers joining sovereign demand. This piec...
A potential policy showdown between a president and the Fed chair could ripple through markets. This piece explains t...
As retirees plan for 2026, three unexpected reasons your Social Security check could shrink surface, from filing timi...
In the latest quarter, many hedge funds bought stakes in RidgePoint Heavy Equipment, a niche rental firm. The move si...
A couple questions how to allocate a house-down payment fund during a layoff. The Ramsey Show host cautions that dipp...
The 2026 IPO boom is broadening beyond AI megadeals as mid-cap and overlooked sectors attract new capital. A busy sec...
tech stocks led a broad rally as Nvidia fueled AI optimism. This look at the stock market today, feb., explains what...
When the PC market slows, smart investors look beyond laptops. A new wave of winners emerges—from memory makers to AI...
XRP continues to slide in March 2026 despite regulatory wins and Brazil expansion, with traders weighing macro risks,...
BTBT's Q4 2025 earnings shed light on mining efficiency, energy spend, and bitcoin price risks. This guide breaks dow...
Public trading disclosures show a sharp spike in activity by the former president, with Trump’s trading volume just s...